期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生物靶向治疗在乳腺癌中应用的最新进展 被引量：2

The Latest Development of Biological Target Therapy in Breast Cancer
下载PDF
导出
摘要 生物靶向治疗是以乳腺癌发生发展相关的分子为靶 ,进行拮抗治疗。笔者综述了针对肿瘤血管生成、生长因子或生长因子受体、细胞凋亡、细胞内信号传导的新药物的研究现状及末来的研究思路。 Biological target therapy is a selective action on targets required for tumor development and progression.This paper reviews the new therapeutic agents,which is related to angiogenesis,growth factor or growth factor receptor,apoptosis,intracellular signaling molecules.We wish to find the more effctive antagonists in the future.
作者 张杰 邵志敏 沈镇宙
机构地区 复旦大学附属肿瘤医院乳腺外科
出处 《肿瘤防治杂志》 2001年第4期434-436,共3页 China Journal of Cancer Prevention and Treatment
关键词 靶向治疗 单克隆抗体 综述文献 乳腺癌 target therapy monoclonal antibody breast cancer review
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1[1]Folkman J.Tumor angiogenesis:therapeutic implications[J].N Eng1 J Med, 1971,285(21): 1182-1186.
  • 2[2]Harris JR,Lippman ME,Morrow M,et al. Disease of the breast[M].Lippincott Williams ( second edition), 1999.799-807.
  • 3[3]Takano S,Gately S,Neville ME,et al .Suramin,an anticancer and angiosuppressive agent,inhibits endothelial cell binding of basic fibroblast growth factor, proliferation, and induction of urokinase-type plasminogen activator [J]. Cancer Res, 1994,54(10) :2654-2660.
  • 4[4]Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J]. Nature, 1997,390 ( 6658 ): 404-407.
  • 5[5]Staddon A,Henry D,Bonnem E.A randomized dose finding study of recombinant human platelet fator4 in cutaneous AIDS-related Kaposi' s sarcoma [J]. Proc Am Soc Clin Oncol, 1994,13: 50.
  • 6[6]Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth[J]. Nature,190,348(6301 ): 555-557.
  • 7[7]Takamiya Y,Brem H,Ojeifo J,et al. AGM-1470 inhibits the growth of the human glioblastoma cells in vitro and in vivo[J ]. Neurosurgery,1994,34(5) :869-875.
  • 8[8]Offodile R,Walton T, Lee M, et al. Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470[J].Tumori, 1999,85(1):51-53.
  • 9[9]Steward WP. Marimastat (BB2516): current status of development.Cancer Chemother Pharmacol, 1999,43(Suppl) :56-60.
  • 10[10]Dabrowska A, Giermasz A, Marczak M, et al. Potentiated antitumor effects of interleukin12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice [J]. Anticancer Res, 2000, 20(1A) :391-394.

同被引文献37

引证文献2

二级引证文献6

肿瘤防治杂志
2001年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部